Subacute pneumopathy during amiodarone therapy

Chest. 1983 Mar;83(3):566-8. doi: 10.1378/chest.83.3.566.

Abstract

A patient with types A and B of Wolff-Parkinson-White syndrome developed subacute pneumonitis during long-term treatment with amiodarone. The pneumopathy occurred only when the maintenance dose was increased to 800 mg/day. Lung specimens obtained by transbronchial biopsy showed chronic pneumonitis with C3 deposition by immunofluorescence. Pulmonary signs spontaneously disappeared two months after the drug was discontinued.

Publication types

  • Case Reports

MeSH terms

  • Amiodarone / administration & dosage
  • Amiodarone / adverse effects*
  • Benzofurans / adverse effects*
  • Female
  • Humans
  • Lung / pathology
  • Middle Aged
  • Pneumonia / chemically induced*
  • Pneumonia / immunology
  • Pneumonia / pathology
  • Wolff-Parkinson-White Syndrome / drug therapy

Substances

  • Benzofurans
  • Amiodarone